-
Signature
-
YuFan Stephanie Wang, Attorney-in-Fact
-
Stock symbol
-
PRGS
-
Transactions as of
-
Jan 31, 2024
-
Transactions value $
-
-$1,566,052
-
Form type
-
4
-
Date filed
-
2/2/2024, 05:32 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
PRGS |
Common Stock |
Options Exercise |
$236K |
+7.5K |
+31.43% |
$31.49 |
31.4K |
Jan 31, 2024 |
Direct |
|
transaction |
PRGS |
Common Stock |
Sale |
-$430K |
-7.5K |
-23.91% |
$57.31 |
23.9K |
Jan 31, 2024 |
Direct |
F1, F2 |
transaction |
PRGS |
Common Stock |
Options Exercise |
$0 |
+37.2K |
+155.73% |
$0.00 |
61K |
Feb 1, 2024 |
Direct |
F3, F4 |
transaction |
PRGS |
Common Stock |
Tax liability |
-$942K |
-16.5K |
-27.01% |
$57.14 |
44.5K |
Feb 1, 2024 |
Direct |
F5 |
transaction |
PRGS |
Common Stock |
Sale |
-$431K |
-7.5K |
-16.84% |
$57.41 |
37K |
Feb 2, 2024 |
Direct |
F1, F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
PRGS |
Employee Stock Options (Right to buy) |
Options Exercise |
$0 |
-7.5K |
-18.57% |
$0.00 |
32.9K |
Jan 31, 2024 |
Common Stock |
7.5K |
$31.49 |
Direct |
F7 |
transaction |
PRGS |
Restricted Stock Units |
Options Exercise |
$0 |
-37.2K |
-100% |
$0.00* |
0 |
Feb 1, 2024 |
Common Stock |
37.2K |
|
Direct |
F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: